Zambia study aims to unlock secrets of rotavirus vaccine failure

NCT ID NCT07626606

Recruiting now Knowledge-focused Sponsor: Centre for Infectious Disease Research in Zambia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why oral rotavirus vaccines are less effective in some low-income countries like Zambia. Researchers will collect blood, stool, and tissue samples from 43 adults to study how gut health and the immune system affect vaccine response. The goal is to find biological clues that could help improve vaccines for children worldwide.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEASIBILITY STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rotavirus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEASIBILITY STUDY ROTA VIRUS GASTROENTERITIS TRANSCRIPTOMICS VACCINE IMMUNE RESPONSE

Contacts and locations

Locations

TROPGAN
RECRUITING

Lusaka, Lusaka Province, P.O.BOX34681LUSAKA,ZAMBIA10101, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.